Supernus Pharmaceuticals, Inc. (SUPN) SEC filings
SUPN SEC filings moved a median of +0.04% by the close. SUPN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the SUPN overview →
82 measured SUPN SEC filing events.
Where these SUPN SEC filings landedvs 82 measured SUPN SEC filing reactions
| Middle 50% of SUPN SEC filing reactions | -1.60% to +1.88% |
|---|---|
| Median reaction (to close) | +0.04% |
| Measured reactions | 82 |
Point-in-time · zero look-ahead
Half of the 82 SUPN SEC filing events with a measured close landed between -1.60% and +1.88%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form DEFA14A SUPERNUS PHARMACEUTICALS | SEC filing · Form DEFA14A | -0.61% | -0.07% | |
| Form DEFM14A SUPERNUS PHARMACEUTICALS | SEC filing · Form DEFM14A | +0.21% | -1.59% | |
| Form 10-Q SUPERNUS PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +1.30% | -8.00% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 01 | SEC filing · Form 8-K | +1.30% | -8.00% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 03 | SEC filing · Form 8-K | +1.30% | -8.00% | |
| Form DEFA14A SUPERNUS PHARMACEUTICALS | SEC filing · Form DEFA14A | +1.30% | -8.00% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Jul 22 | SEC filing · Form 8-K | +0.13% | +1.68% | |
| Form S-8 SUPERNUS PHARMACEUTICALS | SEC filing · Form S-8 | +0.04% | -0.47% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Jun 18 | SEC filing · Form 8-K | +0.38% | -0.04% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: May 17 | SEC filing · Form 8-K | -0.66% | +1.44% | |
| Form 10-Q SUPERNUS PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -0.40% | +1.54% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: May 05 | SEC filing · Form 8-K | -0.40% | +1.54% | |
| Form ARS SUPERNUS PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | -0.58% | -0.35% | |
| Form DEF 14A SUPERNUS PHARMACEUTICALS For: Jun 18 | SEC filing · Form DEF | -0.58% | -0.35% | |
| Form DEFA14A SUPERNUS PHARMACEUTICALS | SEC filing · Form DEFA14A | -0.58% | -0.35% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Apr 22 | SEC filing · Form 8-K | +1.34% | -0.71% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Apr 01 | SEC filing · Form 8-K | +0.44% | -0.69% | |
| Form 10-K SUPERNUS PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -0.09% | +0.53% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Feb 24 | SEC filing · Form 8-K | +1.22% | -0.32% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Feb 12 | SEC filing · Form 8-K | +0.30% | +1.99% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Jan 28 | SEC filing · Form 8-K | +0.39% | +0.66% | |
| Form 10-Q SUPERNUS PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +1.03% | -1.60% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Nov 04 | SEC filing · Form 8-K | +9.80% | +5.39% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Oct 21 | SEC filing · Form 8-K | +0.19% | -0.10% | |
| Form 8-K/A SUPERNUS PHARMACEUTICALS For: Jul 31 | SEC filing · Form 8-K | +0.69% | +0.97% | |
| Form 10-Q SUPERNUS PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +2.11% | +8.40% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 05 | SEC filing · Form 8-K | +2.11% | +8.40% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Jun 16 | SEC filing · Form 8-K | +0.20% | +4.13% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Jul 30 | SEC filing · Form 8-K | +1.95% | +6.91% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Jul 22 | SEC filing · Form 8-K | +0.06% | +0.36% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Jun 16 | SEC filing · Form 8-K | -0.80% | +1.95% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Jun 13 | SEC filing · Form 8-K | -1.78% | +0.31% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: May 22 | SEC filing · Form 8-K | -0.37% | -1.83% | |
| Form 10-Q SUPERNUS PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +6.00% | +2.25% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: May 06 | SEC filing · Form 8-K | +6.00% | +2.25% | |
| Form ARS SUPERNUS PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | -1.78% | +0.43% | |
| Form DEF 14A SUPERNUS PHARMACEUTICALS For: Jun 16 | SEC filing · Form DEF | -1.78% | +0.43% | |
| Form DEFA14A SUPERNUS PHARMACEUTICALS | SEC filing · Form DEFA14A | -1.78% | +0.43% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Apr 23 | SEC filing · Form 8-K | +0.00% | +1.65% | |
| Form 10-K SUPERNUS PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -2.53% | -5.00% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Feb 25 | SEC filing · Form 8-K | -2.53% | -5.00% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Feb 24 | SEC filing · Form 8-K | +0.61% | -0.09% | |
| Form S-8 POS SUPERNUS PHARMACEUTICALS | SEC filing · Form S-8 | +0.61% | -0.09% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Feb 18 | SEC filing · Form 8-K | +3.27% | +2.44% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Feb 11 | SEC filing · Form 8-K | -0.21% | +1.54% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Feb 04 | SEC filing · Form 8-K | -0.62% | -1.99% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Jan 27 | SEC filing · Form 8-K | -0.51% | -0.61% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Dec 19 | SEC filing · Form 8-K | -0.66% | +0.62% | |
| Form 10-Q SUPERNUS PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -2.26% | -8.60% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Nov 04 | SEC filing · Form 8-K | -2.26% | -8.60% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Oct 30 | SEC filing · Form 8-K | -0.58% | -1.79% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Oct 21 | SEC filing · Form 8-K | +0.00% | +0.60% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Oct 17 | SEC filing · Form 8-K | -0.22% | +1.32% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Oct 10 | SEC filing · Form 8-K | -0.06% | +2.58% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 19 | SEC filing · Form 8-K | +0.49% | -0.81% | |
| Form 10-Q SUPERNUS PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +6.20% | +3.40% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 06 | SEC filing · Form 8-K | +6.20% | +3.40% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Aug 01 | SEC filing · Form 8-K | -0.14% | +0.07% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Jul 23 | SEC filing · Form 8-K | +0.00% | +2.29% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Jun 14 | SEC filing · Form 8-K | +0.08% | +2.62% | |
| Form S-8 SUPERNUS PHARMACEUTICALS | SEC filing · Form S-8 | +0.08% | +2.62% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: May 23 | SEC filing · Form 8-K | -0.21% | -1.68% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: May 09 | SEC filing · Form 8-K | -2.01% | -4.55% | |
| Form 10-Q SUPERNUS PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +3.14% | -4.82% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: May 08 | SEC filing · Form 8-K | +3.14% | -4.82% | |
| Form ARS SUPERNUS PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | +0.76% | -0.99% | |
| Form DEF 14A SUPERNUS PHARMACEUTICALS For: Jun 14 | SEC filing · Form DEF | +0.76% | -0.99% | |
| Form DEFA14A SUPERNUS PHARMACEUTICALS | SEC filing · Form DEFA14A | +0.76% | -0.99% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Apr 22 | SEC filing · Form 8-K | -0.60% | -2.40% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Apr 24 | SEC filing · Form 8-K | -0.60% | -2.40% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Apr 08 | SEC filing · Form 8-K | +4.64% | +2.78% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Feb 22 | SEC filing · Form 8-K | -1.53% | -5.14% | |
| Form 10-K SUPERNUS PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +4.27% | +8.75% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Feb 27 | SEC filing · Form 8-K | +4.27% | +8.75% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Feb 14 | SEC filing · Form 8-K | +0.00% | +0.46% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Feb 13 | SEC filing · Form 8-K | +0.00% | +0.58% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Feb 05 | SEC filing · Form 8-K | -0.73% | -0.87% | |
| Form 10-Q SUPERNUS PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -1.64% | +4.56% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Nov 08 | SEC filing · Form 8-K | -1.64% | +4.56% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Nov 01 | SEC filing · Form 8-K | +1.31% | +0.00% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Oct 25 | SEC filing · Form 8-K | +0.00% | -2.86% | |
| Form 8-K SUPERNUS PHARMACEUTICALS For: Oct 18 | SEC filing · Form 8-K | +0.43% | -1.60% |
Keep exploring
More SUPN: earnings → · analyst actions → · SUPN overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Celyad Oncology SA - American Depositary Shares (CYAD) | 504 | 0.00% | 41% |
| DELMAR PHARMACEUTICALS (DMPI) | 504 | -0.13% | 38% |
| CORINDUS VASCULAR ROBOTICS INC (CVRS) | 503 | -0.65% | 37% |
| Teligent, Inc. (TLGT) | 502 | -0.17% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.